Stocks · Health care · Biological Products, (No Diagnostic Substances)

Cullinan Therapeutics, Inc.

CGEM Clue Score48
United States Fiscal year ends December CIK 0001789972 Results filed 6 Aug 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Jennifer Michaelson
25 Feb 2026
Chief Scientific Officer
Sold on a plan
1,780
$14.14
$25.17K
Jennifer Michaelson
24 Feb 2026
Chief Scientific Officer
Sold on a plan
3,601
$14.47
$52.11K
Jennifer Michaelson
23 Feb 2026
Chief Scientific Officer
Sold on a plan
1,752
$13.99
$24.51K
Jennifer Michaelson
22 Jan 2026
Chief Scientific Officer
Sold on a plan
4,000
$12.30
$49.20K
Jennifer Michaelson
19 Dec 2025
Chief Scientific Officer
Sold on a plan
1,345
$10.01
$13.46K
Jennifer Michaelson
15 Dec 2025
Chief Scientific Officer
Sold on a plan
995
$11.90
$11.84K
Jennifer Michaelson
12 Dec 2025
Chief Scientific Officer
Sold on a plan
2,148
$12.38
$26.59K
Jennifer Michaelson
24 Nov 2025
Chief Scientific Officer
Sold on a plan
4,000
$12.30
$49.20K
Jennifer Michaelson
6 Jan 2025
Chief Scientific Officer
Sold on a plan
4,000
$12.51
$50.04K
Jennifer Michaelson
5 Nov 2024
Chief Scientific Officer
Sold on a plan
8,000
$15.64
$125.12K
Jennifer Michaelson
5 Sep 2024
Chief Scientific Officer
Sold on a plan
8,000
$18.09
$144.72K
Jennifer Michaelson
5 Jul 2024
Chief Scientific Officer
Sold on a plan
8,000
$16.33
$130.64K

What was left out

Form 4 filings counted 220
Amendments (4/A) skipped 3
Filings about a different issuer 0
Unreadable filings 0
Joint filings 21
Sales on a Rule 10b5-1 plan 12
Sales straight out of an exercise 34
Sales at will 139
Transactions with no price 0
Shares from compensation/vesting 31,067,955
Sales filed before the plan box existed 81
History held since 11 Jan 2021